Data on Breast Cancer Described by Researchers at Johns Hopkins University (Cost-effectiveness Analysis of Trastuzumab Deruxtecan Versus Trastuzumab Emtansine for Patients With Human Epidermal Growth Factor Receptor 2 Positive Metastatic Breast ...)

Press/Media: Expert Comment

PeriodApr 12 2024

Media coverage

1

Media coverage

  • TitleData on Breast Cancer Described by Researchers at Johns Hopkins University (Cost-effectiveness Analysis of Trastuzumab Deruxtecan Versus Trastuzumab Emtansine for Patients With Human Epidermal Growth Factor Receptor 2 Positive Metastatic Breast ...)
    Media name/outletInsurance Daily News
    Country/TerritoryUnited States
    Date4/12/24
    PersonsYuan Yuan